 |
|
Our
Products |
 |
|
|
|
|
|
|
|
More |
|
|
|
|
|
|
|
|
Also
check out |
|
|
|
|
|
|
|
|
Worldwide
Opportunities
A Free Service
from Anteromas, PT. |
|
| Shanghai Yingxuan Pharmaceutical Science & Technology Co., LTD
- China |
|
| Small
Size Company* (see explanation below) |
| |
| Company: |
Shanghai Yingxuan Pharmaceutical Science & Technology Co., LTD |
| Category: |
Chemicals - Pharmacheuticals |
| Description: |
Shanghai Yingxuan Pharmaceutical Science&Technology Co., LTD is one of the professional Suppliers in Chinese pharmaceutical market. We are specialized in researching and marketing new bulk drugs, new pharmaceutical intermediates and new moleculars.
Our main products include Anti-cancer Drugs(Antineoplastics), Antivirus,Herb Extracts,Pharmaceutical Peptide,Hormones, Antibiotics and Research Standard Samples for Pharmaceutical Studies.Our Products have been exported to U.S.A.,Europe, Japan, South Korea and,etc.Besides,with strong research and production teams equipped with top quality facilities, we can custom synthesize high-purity new bulk drugs, new moleculars,advanced intermediates to your specifications from multi-grams to kilograms.
Quality of our products always complies with international standard, and well accepted by our customers.We have been enjoying a good reputation for the high quality and good services in the world market.Furthermore, Y.X.Pharm. is endeavored in establishing long-term, various, and mutual-benefit cooperation with companies worldwide.
|
| Group: |
Manufacturer |
| Product
Name: |
D-Bicuculline |
| |
celastrol |
| |
Angoroside C |
| |
Entecavir |
| |
Gemcitabine HCL |
| Address: |
pudong,shanghai |
| City,
State: |
Shanghai |
| Zip: |
201206 |
| Country: |
China |
| Phone: |
86-21-50312780 |
| Fax: |
86-21-50312780 |
| Contact
person: |
Tonyliang |
| Email: |
 |
| Site/Misc.: |
www.yingxuanpharm.com |
| Continent: |
North America
|
| Turnover: |
Small
|
| CID: |
19398 |
|
|
* Small: Turnover < 1 million USD/yr
* Medium: Turnover 1 million to 10 millions USD/yr
* Large: Turnover 10 millions and up USD/yr
|
|
|
|
